Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Linda Marban Insider Profile
11 Followers
Linda Marban, CEO, Director at Capricor Therapeutics, holds 198.60K shares in Capricor Therapeutics (Ticker: CAPR).
Linda Marban Capricor Therapeutics (CAPR)CEO, Director
Capricor Therapeutics (CAPR)
CEO, Director
Ranked #43,351 out of 99,218 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+10.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Linda Marban holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 18, 2016 - Mar 18, 2017
Return:+26.90%
The most profitable trade made by Linda Marban
Linda Marban's Trading History
List of latest transactions for each holding click on a transaction to see Linda Marban's performance on stock
You May Also Like
Linda Marban insider profile FAQ
What is the percentage of profitable transactions made by Linda Marban?
The percentage of profitable transactions made by Linda Marban is 50%.
What is the average return per transaction made by Linda Marban?
The average return per transaction made by Linda Marban is 10.90%.
What stocks does Linda Marban hold?
Linda Marban holds: CAPR stocks.
What was Linda Marban’s latest transaction?
Linda Marban latest transaction was an Uninformative Buy of $28.84K.
What was Linda Marban's most profitable transaction?
Linda Marban’s most profitable transaction was an Informative Buy of CAPR stock on March 18, 2016. The return on the trade was 26.90%.
What is Linda Marban's role in Capricor Therapeutics?
Linda Marban's role in Capricor Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.